2024 | Seroprevalence of anti-diphtheria toxoid antibody and implications for vaccination policy in Vietnam's South-central coast: a cross-sectional study
| BMC INFECTIOUS DISEASES |
2024 | Association between sleep patterns and alcohol use disorders in workers
| PLOS ONE |
2024 | Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations
| MOLECULAR CANCER THERAPEUTICS |
2024 | Association between the utilization of senior centers and participation in health check-ups
| SCIENTIFIC REPORTS |
2024 | Effect of the peripartum depressive symptoms on the Internet use disorder of their offspring in late childhood: retrospective longitudinal study
| SCIENTIFIC REPORTS |
2023 | Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in <i>FGFR</i>-altered breast cancer
| SCIENTIFIC REPORTS |
2023 | Association between changes in having of cancer patients in the family and depression: A longitudinal panel study
| JOURNAL OF AFFECTIVE DISORDERS |
2023 | 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib
| COMMUNICATIONS BIOLOGY |
2023 | Estimating causal effects with hidden confounding using instrumental variables and environments
| Electronic Journal of Statistics |
2023 | A unified mediation analysis framework for integrative cancer proteogenomics with clinical outcomes
| BIOINFORMATICS |
2022 | A Bayesian precision medicine framework for calibrating individualized therapeutic indices in cancer | ANNALS OF APPLIED STATISTICS |
2022 | Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes | HEPATOLOGY |
2022 | CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
| SCIENTIFIC REPORTS |
2022 | Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study | INTERNATIONAL JOURNAL OF CANCER |
2022 | TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
| COMMUNICATIONS BIOLOGY |